Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06465043Recruiting

HFPEF-project: Heart Failure Phenotyping - Exploring the Fingerprints

Role: collaborator

NCT01742702Unknown

HaemoDYNAMICs in Primary and Secondary Hypertension

Role: collaborator

NCT02648464Phase 4Completed

Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial

Role: collaborator

NCT01374867Completed

CardShock Study and Registry

Role: collaborator

All 4 trials loaded